BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen SS, Huang Y, Guo YM, Li SS, Shi Z, Niu M, Zou ZS, Xiao XH, Wang JB. Serum Metabolomic Analysis of Chronic Drug-Induced Liver Injury With or Without Cirrhosis. Front Med (Lausanne) 2021;8:640799. [PMID: 33855035 DOI: 10.3389/fmed.2021.640799] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Moreno-Torres M, Quintás G, Castell JV. The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment. Metabolites 2022;12:564. [PMID: 35736496 DOI: 10.3390/metabo12060564] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Zhao YW, Yang J, Niu J, Wang T, Liang XD, Ren Y, Wang R. Pharmacodynamic Evaluation of the Gexia Zhuyu Decoction in the Treatment of NAFLD and the Molecular Mechanism Underlying the TRPM4 Pathway Regulation. Evid Based Complement Alternat Med 2021;2021:3364579. [PMID: 34887931 DOI: 10.1155/2021/3364579] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Zeng L, Chen N, Liao J, Shen X, Song S, Wang F. Metabolic Analysis of Potential Key Genes Associated with Systemic Lupus Erythematosus Using Liquid Chromatography-Mass Spectrometry. Comput Math Methods Med 2021;2021:5799348. [PMID: 34646335 DOI: 10.1155/2021/5799348] [Reference Citation Analysis]